0

Purchase Short-Term Access

Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
Stuart J. Connolly, MD; John W. Eikelboom, MBBS; Jennifer Ng, MSc; Jack Hirsh, MD; Salim Yusuf, MD; Janice Pogue, MSc, MA; Raffaele de Caterina, MD, PhD; Stefan Hohnloser, MD; Robert G. Hart, MD; on behalf of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators
Annals of Internal Medicine 2011;155:579-586. doi:10.7326/0003-4819-155-9-201111010-00004

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)